查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824458

2025年全球单细胞基因组定序市场报告

Single-Cell Genome Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年单细胞基因组定序市场将快速成长，到2029年将达到50.2亿美元，复合年增长率为15.4%。预测期内的成长归因于自体免疫疾病盛行率的上升、神经系统疾病的增加、政府倡议和资金的增加、合约研究组织 (CRO) 的增加以及人们对scRNA-seq潜力的认识不断提高。预测期内的主要趋势包括单细胞定序技术的演变、单细胞体学技术的发展、加速进展的合作倡议、创新解决方案以及主要企业之间的伙伴关係。

未来五年15.4%的成长率预测较先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国，导致其从以色列和英国进口的微流体单细胞分离套件和条码试剂成本上升，减缓癌症异质性研究，并增加研究机构的预算。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

预计癌症发生率的上升将推动未来单细胞基因组定序市场的成长。癌症是一类以细胞不受控制的生长为特征的多样化疾病，原因是基因改变影响细胞分裂和正常细胞功能。这种疾病的特征是基因改变，而单细胞基因组定序对于在单一癌细胞层面上揭示这些基因改变非常有用。例如，2023 年 1 月，美国癌症协会报告称，2022 年美国将新增约 190 万例癌症病例，癌症相关死亡人数为 609,360 人。预测数字将进一步增加，到 2040 年预计将新增 2,750 万例癌症病例，癌症相关死亡人数为 1,630 万人。因此，预计癌症发生率的上升将推动单细胞基因组定序市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球单细胞基因组定序：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球单细胞基因体定序市场：成长率分析
  • 全球单细胞基因组定序市场表现：规模与成长，2019-2024
  • 全球单细胞基因组定序市场预测：规模与成长，2024-2029年，2034年
  • 全球单细胞基因组定序：总潜在市场（TAM）

第六章 市场细分

  • 全球单细胞基因组定序市场：按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 全球单细胞基因组定序市场：依技术、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • 定量聚合酵素链锁反应（qPCR）
  • 微阵列
  • 多重重置换扩增（MDA）
  • 全球单细胞基因组定序市场：依治疗领域、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 免疫学
  • 产前检查
  • 神经生物学
  • 微生物学
  • 其他疾病领域
  • 全球单细胞基因体定序市场：应用、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 循环细胞
  • 细胞分化或重编程
  • 基因组突变
  • 亚群特征
  • 其他用途
  • 全球单细胞基因组定序市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究办公室
  • 生物技术和生物製药公司
  • 诊所
  • 其他最终用户
  • 全球单细胞基因组定序市场：按仪器类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 单细胞分离系统
  • 定序平台
  • 自动化和机器人系统
  • 全球单细胞基因组定序市场：按试剂类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 文库製备试剂套件
  • 扩增试剂
  • DNA萃取试剂套件
  • 品管试剂

第七章 区域和国家分析

  • 全球单细胞基因组定序市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球单细胞基因组定序市场：依国家、地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 单细胞基因组定序市场：竞争格局
  • 单细胞基因组定序市场：公司简介
    • F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • DH Life Sciences LLC. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson And Company（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN GmbH
  • Bio-Techne Corporation
  • BGI Genomics Co. Ltd.
  • Fulgent Genetics Inc.
  • 10x Genomics Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc.
  • Standard BioTools Inc.
  • Singleron Biotechnologies
  • MGI Tech Co. Ltd
  • GENEWIZ Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年单细胞基因组定序市场：提供新机会的国家
  • 2029年单细胞基因组定序市场：细分领域带来新机会
  • 2029年单细胞基因组定序市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25299u

Single-cell genome sequencing is a powerful method for detecting genomic changes such as copy number variations (CNVs) and point mutations, as well as revealing cell-to-cell heterogeneity in biological materials. It is employed to investigate both healthy and diseased physiology.

The main types of single-cell genome sequencing include instruments and reagents. Instruments refer to specialized equipment or devices used to perform the various steps involved in the sequencing process. Various technologies, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), quantitative polymerase chain reaction (qPCR), microarray, and multiple displacement amplification (MDA), are utilized in disease areas such as cancer, immunology, prenatal diagnosis, neurobiology, microbiology, and others. The applications encompass circulating cells, cell differentiation or reprogramming, genomic variation, subpopulation characterization, and others, serving academic research laboratories, biotechnology biopharmaceutical companies, clinics, and other related entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The single-cell genome sequencing market research report is one of a series of new reports from The Business Research Company that provides single-cell genome sequencing market statistics, including single-cell genome sequencing industry global market size, regional shares, competitors with a single-cell genome sequencing market share, detailed single-cell genome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell genome sequencing industry. This single-cell genome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell genome sequencing market size has grown rapidly in recent years. It will grow from $2.49 billion in 2024 to $2.83 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to increased understanding of genetic heterogeneity, rising demand for precision medicine, increased cancer research, growth in prevalence of infectious diseases, increased healthcare spending.

The single-cell genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.02 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing prevalence of autoimmune diseases, increasing neurological disorders, increasing government initiatives and funding, rise of contract research organizations (cros), increasing awareness of scrna-seq's potential. Major trends in the forecast period include advancements in single-cell sequencing technologies, development of single-cell multi-omics technologies, collaborative initiatives to accelerate advancements, innovative solutions, and key players' partnerships.

The forecast of 15.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of microfluidic single-cell isolation kits and barcoding reagents sourced from Israel and the UK, thereby slowing cancer heterogeneity studies and elevating research institution budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cancer prevalence is expected to drive the growth of the single-cell genome sequencing market in the future. Cancer, a diverse group of diseases characterized by uncontrolled cell growth, is a result of genetic changes affecting cell division and normal cellular functions. The disease is marked by genetic alterations, and single-cell genome sequencing proves invaluable in revealing these genetic changes at the individual cancer cell level. For example, in January 2023, the American Cancer Society reported approximately 1.9 million new cancer cases and 609,360 cancer-related deaths in the US in 2022. Predictions indicate a further increase, with an estimated 27.5 million new cancer cases and 16.3 million cancer deaths projected by 2040. Consequently, the rising incidence of cancer is expected to be a driving factor for the growth of the single-cell genome sequencing market.

The remarkable expansion of genomic data is a substantial contributor to the ongoing growth of the single-cell genome sequencing market. Genomic data encompasses information related to the structure and function of an organism's genome. The exponential increase in genomic data generated through single-cell sequencing opens up opportunities for data analysis, interpretation, and the development of bioinformatics tools, fostering market growth. As per a 2022 report from the National Human Genome Research Institute (NHGRI), the genomic data is projected to reach between 2 and 40 exabytes within the next decade. Hence, the rapid surge in genomic data is poised to propel the single-cell genome sequencing market.

Technological advancements emerge as a noteworthy trend gaining traction in the single-cell genome sequencing market. Leading companies in the sector are dedicated to developing technologically advanced solutions to enhance their market position. For instance, in May 2023, Mission Bio Inc., a US-based company specializing in single-cell multi-omics platforms, introduced the Tapestri Genome Editing Solution. This end-to-end product for genome editing analysis is expected to be a more effective analytical tool for developing next-generation gene-edited drugs, offering single-cell insights capable of impacting efficacy and safety.

Major players in the single-cell genome sequencing market are concentrating on the development of single-cell proteomics, a nascent discipline seeking to understand the diversity of protein expression within individual cells. Integrating single-cell genomics with proteomics techniques allows for studying the relationship between genomic information and protein expression at the single-cell level. For example, in October 2023, Proteome Sciences plc, a UK-based biotechnology company, launched SysQuant SCP, a single-cell proteomics commercial service. Leveraging the capabilities of its TMTpro isobaric labelling reagents, SysQuant SCP generates and analyzes quantitative mass spectrometry data to uncover subtle variations in individual cells and within subpopulations of the same primary cell type. This data is expected to advance our understanding of biological drivers of heterogeneity and evolution in disease contexts and therapy responses, providing new targets for personalized medicine.

In January 2023, Qiagen, a Germany-based pharmaceutical research company, acquired Verogen for an undisclosed amount. This acquisition aims to strengthen Qiagen's position in human identification and forensic testing by incorporating Verogen's NGS technology and expertise. Verogen is a biotechnology company based in the United States.

Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single-cell genome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single-cell genome sequencing market consists of revenues earned by entities by providing single-cell analysis, genetic heterogeneity study, identification of genomes of individual cells, and microbiomes and cancer study. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-cell genome sequencing market also includes sales of single cell kit, DNA sequencing instruments and single-cell sequencing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Cell Genome Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-cell genome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell genome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-cell genome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Instruments; Reagents
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Quantitative Polymerase Chain Reaction (qPCR); Microarray; Multiple Displacement Amplification (MDA)
  • 3) By Disease Area: Cancer; Immunology; Prenatal Diagnosis; Neurobiology; Microbiology; Other Disease Areas
  • 4) By Application: Circulating Cells; Cell Differentiation Or Reprogramming; Genomic Variation; Subpopulation Characterization; Other Applications
  • 5) By End User: Academic Research Laboratories; Biotechnology Biopharmaceutical Companies; Clinics; Other End Users
  • Subsegments:
  • 1) By Instruments: Single-Cell Isolation Systems; Sequencing Platforms; Automation And Robotic Systems
  • 2) By Reagents: Library Preparation Kits; Amplification Reagents; DNA Extraction Kits; Quality Control Reagents
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; DH Life Sciences LLC.; Becton Dickinson And Company (BD); Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN GmbH; Bio-Techne Corporation; BGI Genomics Co. Ltd.; Fulgent Genetics Inc.; 10x Genomics Inc.; Promega Corporation; Takara Bio Inc.; Oxford Nanopore Technologies PLC; Pacific Biosciences of California Inc.; Standard BioTools Inc.; Singleron Biotechnologies; MGI Tech Co. Ltd; GENEWIZ Inc.; Mission Bio Inc.; Zymo Research Corporation; Menarini Silicon Biosystems SpA; Novogene Co. Ltd.; RareCyte Inc.; Fluxion Biosciences Inc.; Single Cell Discoveries B.V.; Parse Biosciences Inc.; BioSpyder Technologies Inc.; SeqWell Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Single-Cell Genome Sequencing Market Characteristics

3. Single-Cell Genome Sequencing Market Trends And Strategies

4. Single-Cell Genome Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Single-Cell Genome Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Single-Cell Genome Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Single-Cell Genome Sequencing Market Growth Rate Analysis
  • 5.4. Global Single-Cell Genome Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Single-Cell Genome Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Single-Cell Genome Sequencing Total Addressable Market (TAM)

6. Single-Cell Genome Sequencing Market Segmentation

  • 6.1. Global Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • 6.2. Global Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Quantitative Polymerase Chain Reaction (qPCR)
  • Microarray
  • Multiple Displacement Amplification (MDA)
  • 6.3. Global Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Immunology
  • Prenatal Diagnosis
  • Neurobiology
  • Microbiology
  • Other Disease Areas
  • 6.4. Global Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Circulating Cells
  • Cell Differentiation Or Reprogramming
  • Genomic Variation
  • Subpopulation Characterization
  • Other Applications
  • 6.5. Global Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic Research Laboratories
  • Biotechnology Biopharmaceutical Companies
  • Clinics
  • Other End Users
  • 6.6. Global Single-Cell Genome Sequencing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell Isolation Systems
  • Sequencing Platforms
  • Automation And Robotic Systems
  • 6.7. Global Single-Cell Genome Sequencing Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Library Preparation Kits
  • Amplification Reagents
  • DNA Extraction Kits
  • Quality Control Reagents

7. Single-Cell Genome Sequencing Market Regional And Country Analysis

  • 7.1. Global Single-Cell Genome Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Single-Cell Genome Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Single-Cell Genome Sequencing Market

  • 8.1. Asia-Pacific Single-Cell Genome Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Single-Cell Genome Sequencing Market

  • 9.1. China Single-Cell Genome Sequencing Market Overview
  • 9.2. China Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Single-Cell Genome Sequencing Market

  • 10.1. India Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Single-Cell Genome Sequencing Market

  • 11.1. Japan Single-Cell Genome Sequencing Market Overview
  • 11.2. Japan Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Single-Cell Genome Sequencing Market

  • 12.1. Australia Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Single-Cell Genome Sequencing Market

  • 13.1. Indonesia Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Single-Cell Genome Sequencing Market

  • 14.1. South Korea Single-Cell Genome Sequencing Market Overview
  • 14.2. South Korea Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Single-Cell Genome Sequencing Market

  • 15.1. Western Europe Single-Cell Genome Sequencing Market Overview
  • 15.2. Western Europe Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Single-Cell Genome Sequencing Market

  • 16.1. UK Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Single-Cell Genome Sequencing Market

  • 17.1. Germany Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Single-Cell Genome Sequencing Market

  • 18.1. France Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Single-Cell Genome Sequencing Market

  • 19.1. Italy Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Single-Cell Genome Sequencing Market

  • 20.1. Spain Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Single-Cell Genome Sequencing Market

  • 21.1. Eastern Europe Single-Cell Genome Sequencing Market Overview
  • 21.2. Eastern Europe Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Single-Cell Genome Sequencing Market

  • 22.1. Russia Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Single-Cell Genome Sequencing Market

  • 23.1. North America Single-Cell Genome Sequencing Market Overview
  • 23.2. North America Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Single-Cell Genome Sequencing Market

  • 24.1. USA Single-Cell Genome Sequencing Market Overview
  • 24.2. USA Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Single-Cell Genome Sequencing Market

  • 25.1. Canada Single-Cell Genome Sequencing Market Overview
  • 25.2. Canada Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Single-Cell Genome Sequencing Market

  • 26.1. South America Single-Cell Genome Sequencing Market Overview
  • 26.2. South America Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Single-Cell Genome Sequencing Market

  • 27.1. Brazil Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Single-Cell Genome Sequencing Market

  • 28.1. Middle East Single-Cell Genome Sequencing Market Overview
  • 28.2. Middle East Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Single-Cell Genome Sequencing Market

  • 29.1. Africa Single-Cell Genome Sequencing Market Overview
  • 29.2. Africa Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Single-Cell Genome Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Single-Cell Genome Sequencing Market Competitive Landscape
  • 30.2. Single-Cell Genome Sequencing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. DH Life Sciences LLC. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson And Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Single-Cell Genome Sequencing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN GmbH
  • 31.4. Bio-Techne Corporation
  • 31.5. BGI Genomics Co. Ltd.
  • 31.6. Fulgent Genetics Inc.
  • 31.7. 10x Genomics Inc.
  • 31.8. Promega Corporation
  • 31.9. Takara Bio Inc.
  • 31.10. Oxford Nanopore Technologies PLC
  • 31.11. Pacific Biosciences of California Inc.
  • 31.12. Standard BioTools Inc.
  • 31.13. Singleron Biotechnologies
  • 31.14. MGI Tech Co. Ltd
  • 31.15. GENEWIZ Inc.

32. Global Single-Cell Genome Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single-Cell Genome Sequencing Market

34. Recent Developments In The Single-Cell Genome Sequencing Market

35. Single-Cell Genome Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Single-Cell Genome Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Single-Cell Genome Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Single-Cell Genome Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer